These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 11194316)
1. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation. Linas BP; Coffin PO; Backes G; Vlahov D J Urban Health; 2000 Dec; 77(4):768-80. PubMed ID: 11194316 [TBL] [Abstract][Full Text] [Related]
2. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. Coffin PO; Linas BP; Factor SH; Vlahov D J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317 [TBL] [Abstract][Full Text] [Related]
3. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley. Pollini RA J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658 [TBL] [Abstract][Full Text] [Related]
4. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices. Wright-De Agüero L; Weinstein B; Jones TS; Miles J J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632 [TBL] [Abstract][Full Text] [Related]
5. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. Lewis BA; Koester SK; Bush TW J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S46-51. PubMed ID: 12489615 [TBL] [Abstract][Full Text] [Related]
6. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law. Case P; Beckett GA; Jones TS J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S94-101. PubMed ID: 9663631 [TBL] [Abstract][Full Text] [Related]
7. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws. Gleghorn AA; Gee G; Vlahov D J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S89-93. PubMed ID: 9663630 [TBL] [Abstract][Full Text] [Related]
8. Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City. Coffin PO; Fuller C; Blaney S; Vadnai L; Miller S; Vlahov D Clin Infect Dis; 2004 Feb; 38(3):438-41. PubMed ID: 14727219 [TBL] [Abstract][Full Text] [Related]
9. What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey. Klein SJ; Harris-Valente K; Candelas AR; Radigan M; Narcisse-Pean M; Tesoriero JM; Birkhead GS J Urban Health; 2001 Dec; 78(4):679-89. PubMed ID: 11796814 [TBL] [Abstract][Full Text] [Related]
10. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993. Valleroy LA; Weinstein B; Jones TS; Groseclose SL; Rolfs RT; Kassler WJ J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):73-81. PubMed ID: 7648288 [TBL] [Abstract][Full Text] [Related]
11. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. Rich JD; Martin EG; Macalino GE; Paul RV; McNamara S; Taylor LE J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S58-61. PubMed ID: 12489617 [TBL] [Abstract][Full Text] [Related]
12. Nonprescription syringe sales: Resistant pharmacists' attitudes and practices. Chiarello E Drug Alcohol Depend; 2016 Sep; 166():45-50. PubMed ID: 27423213 [TBL] [Abstract][Full Text] [Related]
13. Impact of new legislation on needle and syringe purchase and possession--Connecticut, 1992. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1993 Mar; 42(8):145-8. PubMed ID: 8437544 [TBL] [Abstract][Full Text] [Related]
14. Pharmacists' attitudes and practices about selling syringes to people who inject drugs in Tajikistan: Results of a syringe purchase audit and a survey. Ibragimov U; Haardörfer R; Cooper HLF; Dunkle KL; Zule WA; Wong FY Int J Drug Policy; 2019 Sep; 71():62-72. PubMed ID: 31226505 [TBL] [Abstract][Full Text] [Related]
15. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution? Lurie P; Jones TS; Foley J J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623 [TBL] [Abstract][Full Text] [Related]
16. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003. Deibert RJ; Goldbaum G; Parker TR; Hagan H; Marks R; Hanrahan M; Thiede H Am J Public Health; 2006 Aug; 96(8):1347-53. PubMed ID: 16809607 [TBL] [Abstract][Full Text] [Related]
17. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Fuller CM; Ahern J; Vadnai L; Coffin PO; Galea S; Factor SH; Vlahov D J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S77-82. PubMed ID: 12489621 [TBL] [Abstract][Full Text] [Related]
18. Nonprescription syringe sales: a missed opportunity for HIV prevention in California. Pollini RA; Rudolph AE; Case P J Am Pharm Assoc (2003); 2015; 55(1):31-40. PubMed ID: 25575149 [TBL] [Abstract][Full Text] [Related]
19. Community Impact of Pharmacy-Randomized Intervention to Improve Access to Syringes and Services for Injection Drug Users. Crawford ND; Amesty S; Rivera AV; Harripersaud K; Turner A; Fuller CM Health Educ Behav; 2014 Aug; 41(4):397-405. PubMed ID: 24722219 [TBL] [Abstract][Full Text] [Related]
20. Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange. Goodin A; Fallin-Bennett A; Green T; Freeman PR Harm Reduct J; 2018 Jan; 15(1):4. PubMed ID: 29370808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]